AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Nov 4, 2024

3377_rpt_2024-11-04_5dfc5d53-d7a9-4fb4-bb48-b1b8ec6a8e9d.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management h1 {font-size: 1.8em;}h2 {font-size: 1.6em}

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen restricted stock units (RSU) program.

Please read the full announcement in PDF.

Talk to a Data Expert

Have a question? We'll get back to you promptly.